The data illustrates the total pharmaceutical and biotech product revenues in the USA products five years after launch, from 2007 to 2017. In 2010, product revenues in the United States totaled 12.5 billion USD for products launched 5 years before.
Pharma and biotech products
Newer pharmaceutical and biotechnology products have generated increasingly large amounts of revenues after five years of launch. In 2008, revenues were at 5.6 billion USD but had skyrocketed to some 31 billion USD in 2017. The average cost of developing a new pharmaceutical or biotech entity has increased from 451 million USD in 1991 to some 1.
